Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine
2006

Rabies Vaccine Study with Cationic Lipids

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Margalith Michal, Vilalta Adrián

Primary Institution: Vical Incorporated

Hypothesis

Can cationic lipid formulations enhance the effectiveness of pDNA rabies vaccines?

Conclusion

The study found that cationic lipid formulations can significantly enhance the humoral response to rabies pDNA vaccines.

Supporting Evidence

  • Vaccination with DMRIE-DOPE-formulated pDNA resulted in high levels of neutralizing antibodies that persisted for at least 195 days.
  • Vaxfectin™-formulated pDNA induced higher neutralizing titers than DMRIE-DOPE in mice.
  • A single administration of 10 μg of pDNA elicited neutralizing titers almost two orders of magnitude over the protective threshold.

Takeaway

This study shows that a special type of vaccine can help protect against rabies for a long time with just one shot.

Methodology

Mice and rabbits were vaccinated with different formulations of pDNA and their antibody responses were measured over time.

Limitations

The study primarily involved animal models, and results may not directly translate to humans.

Participant Demographics

Female BALB/c mice and New Zealand white rabbits were used in the study.

Statistical Information

P-Value

0.004

Statistical Significance

p = 0.004

Digital Object Identifier (DOI)

10.1186/1479-0556-4-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication